Nevertheless, it is known that exogenous administration of IL-13 or IL-4 reduces the incidence and delays the onset of diabetes in the NOD mouse model of type 1 diabetes [10, 19] and that IL-4 and IL-13 each exert direct pro-survival effects in human pancreatic islet cells [20–22]. The gene discussed is IL4; the disease is type 1 diabetes mellitus.